Gelsolin降低小鼠肝癌高淋巴道转移力Hca-F细胞株的侵袭和运动能力
|
摘要
背景:癌的侵袭与转移是癌细胞与宿主细胞、细胞外基质( extracellular matrix,ECM)之间一系列复杂的、多步骤的、多因素相互作用的动态过程。细胞骨架是横越在真核细胞细胞核和细胞膜内侧面的一种纤维状蛋白基质,由微丝、微管及中间纤维组成;三者高度协调分布,与胞核、质膜、细胞器相连构成了细胞形态骨架和运动协调系统,以保持细胞的形态和行使运动功能,并对信号传递有重要意义。近年的研究发现,细胞骨架与细胞遗传物质的复制、传递、遗传信息的表达,即与细胞的分裂、分化、凋亡、癌变等细胞生理功能改变密切相关。Hca-F细胞和Hca-P细胞是一对来源于同一小鼠肝癌细胞克隆、淋巴道转移潜能显著不同、能够稳定传代的亚克隆细胞系。经615小鼠局部皮下注射后,均特异地向引流淋巴结转移。Hca-F细胞和Hca-P细胞分别为高淋巴结转移和低淋巴道转移细胞株,在615小鼠内淋巴结转移率分别大于70%和小于30%,是研究癌症淋巴道转移机制难得的细胞株模型。
本组前期利用基因芯片技术,比较Hca-F细胞和Hca-P细胞之间差异性基因的表达情况,其中gelsolin基因在Hca-F细胞中的表达是Hca-P细胞表达的21.9倍。然而蛋白质是生命活动的体现者,可以说是执行者;基因对性状的控制,是通过控制蛋白质的合成来实现的,因此基因的功能还需要在蛋白水平予以进一步检验和确认。所以我们又通过荧光差异双向凝胶电泳技术,建立了高低淋巴道转移力小鼠肝癌细胞荧光差异蛋白表达图谱,高通量筛选与肿瘤淋巴道转移相关的蛋白质,gelsolin蛋白在Hca-F细胞中的表达是在Hca-P细胞表达的1.7倍,提示其在肝癌的淋巴道转移中发挥着一定的作用。肝癌的淋巴道转移是一个多基因多步骤的过程,研究gelsolin在淋巴道转移过程中的作用和地位,有利于研究肝癌淋巴道转移机制和治疗。
目的:1.从蛋白质水平上比较蛋白质组学筛出的差异蛋白gelsolin在淋巴道转移潜能不同小鼠肝癌细胞系中的表达。2.构建pSilencer-gelsolin-shRNA表达载体,稳定转染Hca-F细胞并获得gelsolin的表达水平稳定下调的Hca-F细胞株,同时建立稳定转染pSilencer-无关序列Hca-F细胞株作为对照。3.研究gelsolin在细胞内的表达和下调其在Hca-F细胞株的表达对小鼠肝癌细胞株Hca-F在细胞增殖、细胞迁移和侵袭能力方面的影响,由此确定gelsolin与小鼠肝癌细胞淋巴道转移潜能间的关系。
方法:1.采用细胞免疫组化、蛋白免疫印迹方法检测gelsolin蛋白在Hca-F、Hca-P细胞株中表达有无差异,为进一步研究肝癌淋巴道转移的机制奠定基础。2.依据GeneBank中小鼠gelsolin基因序列(序列登录号:NM_227753)合成三条shRNA的DNA模板的两条单链,分别命名为gelsolin1、gelsolin2、gelsolin3和gelsolin无关序列,将pSilencer ?3.1-H1neo质粒双酶切后分别与三条shRNA的DNA模板和无关序列的退火后产物连接,连接产物分别命名为pSilencer-shRNA-gelsolin-1、pSilencer-shRNA-gelsolin-2、pSilencer-shRNA-gelsolin-3、pSilencer- shRNA-wg。对三条pSilencer-shRNA表达载体经测序鉴定准确后(引物为5'-GTTTTCCCAGTCACGAC-3'),将三条pSilencer-shRNA表达载体和无关序列对照组分别以脂质体法稳定转染Hca-F细胞,用含400μg/mlG418的完全培养基筛选,获得pSilencer-shRNA-gelsolin表达载体稳定转染的Hca-F细胞和无关序列对照组细胞。提取未处理的Hca-F细胞株、稳转pSilencer无关序列的Hca-F细胞株、稳pSilencer- gelsolin-shRNA三条表达载体的Hca-F细胞株的RNA、蛋白,RT-PCR和Western-Blotting检测shRNA转染后Hca-F细胞gelsolin在mRNA和蛋白质水平的表达。选出下调效果最好的一组细胞株用于后续实验。3.以三组细胞(分别为未处理的Hca-F细胞株、稳染了pSilencer无关序列的Hca-F细胞株、稳转pSilencer-shRNA-gelsolin-1表达载体的Hca-F细胞株)为实验对象。以CCK-8法检测三组细胞的细胞活力和分裂增殖能力;Transwell实验检测三组细胞的体外迁移能力(Transwell小室不做处理)、和侵袭能力(在Transwell上室中加人工基底膜);分别在615小鼠足垫内侧接种三组细胞,2×106个/0.05ml细胞,28天后观察各组淋巴结肿瘤转移情况。
结果:1.Gelsolin在小鼠腹水型肝癌细胞系Hca-F细胞和Hca-P细胞胞浆中表达,Western-blot分析显示gelsolin在Hca-F细胞中高表达,在Hca-P细胞中表达较低(P<0.05)。2.经酶切电泳分析及DNA测序鉴定,成功构建三条重组质粒,并转入Hca-F细胞;与未作处理的Hca-F细胞相比三组重组质粒gelsolin在mRNA水平的抑制率分别为46.8%、48.2%、20%;在蛋白水平对gelsolin的抑制率分别为76.4%、50.4%、37.4%;其中pSilencer-gelsolin-shRNA-1稳定转染的Hca-F细胞株gelsolin下调效果最明显(P<0.01),选择作为后续功能实验研究的gelsolin稳定下调的细胞株。3.CCK-8检测细胞增殖活性显示gelsolin不影响细胞的增殖;体外迁移实验,通过比较穿过膜的细胞在A570吸光值由Hca-F的(0.2480±0.0447)、对照组的(0.2239±0.0274)减少到干扰组细胞(0.1716±0.0232)(P<0.05);体外侵袭实验,比较穿过人工基地膜Hca-F细胞(0.2007±0.0129)、对照组(0.2236±0.0446)和干扰组细胞(0.1557±0.0051),可以发现下调gelsolin蛋白表达后,干扰组细胞穿过人工基底膜的细胞A570 OD值吸光度值较对照降低(P<0.05),结果显示下调Hca-F细胞中gelsolin的表达后,转移的肿瘤细胞数量减少,癌细胞的运动侵袭能力下降;体内淋巴结转移实验显示,下调gelsolin抑制了Hca-F细胞在小鼠体内淋巴结的转移率。
结论:1.Gelsolin在小鼠腹水型肝癌细胞系Hca-F和Hca-P均有表达,且Hca-F中较高,而在Hca-P中表达较低。2.利用pSilencer?3.1-H1neo质粒和shRNA成功构建了三个pSilencer-gelsolin-shRNA表达载体,该载体转染Hca-F细胞细胞后,经含有400μg/mlG418的完全培养基筛选,获得了稳定转染pSilencer-gelsolin-shRNA表达载体的Hca-F细胞株,在成功构建的shRNA稳定转染的Hca-F细胞中,其中pSilencer- gelsolin-shRNA-1对Hca-F细胞中gelsolin抑制效果最明显,作为后续研究的细胞株。3.Gelsolin具有增强肿瘤细胞迁移和侵袭的能力,抑制gelsolin基因和蛋白的表达,具有下调鼠源肝癌细胞转移和侵袭能力的作用,证明在肝癌的淋巴道转移过程中gelsolin发挥着重要的作用。
Background: Many biological processes, such as embryonic morpho- genesis, immune surveillance, and tissue repair and regeneration, are required for cell migration which drives progression of many diseases, including cancer invasion and metastasis.
Cell migration is a highly integrated multistep process which is initiated by the protrusion of cell membrane. In the process of tumor invasion and metastasis, the relationship among tumor cell,host cell and extracellular matrix (ECM) is complicated. The actin cytoskeleton is crucial for cell motility, and it connects with cell disintegration, cell differentiation, apoptosis and canceration. Gelsolin is best known for its involvement in dynamic changes in the actin cytoskeleton during a variety of forms of cell motility.
Hca-P and Hca-F is a pair of syngenetic mouse hepatocarcinoma ascites cell lines, presenting a specific potential of lymphatic metastasis when inoculated subcutaneously in 615 mice. Hca-F with a high metastasis potential (>70%) and Hca-P with a low one (<30%) are rare and available cell model as a control to each other in the research on the molecular mechanisms of lymphatic metastasis.
Based on the gene chip experiment, we found that the expression of gelsolin in Hca-F cells was higher than that in Hca-P cells (21.9 fold compared with Hca-P cells). In order to obtain lymphatic metastasis associated proteins, the protein expressed profiles of Hca-F cells and Hca-P cells were compared using fluorescent two-dimensional difference gel electrophoresis (2D DIGE).Gelsolin protein was up-regulated in Hca-F cells (1.7 fold compared with Hca-P cells) . It was suggestted that gelsolin was a lymph node metastasis-associated protein.
Objective: 1. To observed the expression of gelsolin in Hca-F cells and Hca-P cells. 2. Down-regulating the gelsolin expression in Hca-F cells by using pSilencer 3.1-shRNA expressing vectors. 3. To investigate the effect of gelsolin on the proliferation and invasion of mouse hepatocarcinoma cell lines.
Method:1. Immunohistochemistry and western blot were utilized to show the expression of gelsolin in Hca-F cells and Hca-P cells. 2. Three shRNAs and scrambled shRNA sequences were designed and synthesized according to gelsolin gene sequences .Then three shRNAs and scrambled shRNA sequences were inserted into the pSilencer-3.1 vector to silence gelsolin gene ,and named gelsolin1、gelsolin2、gelsolin3 and gelsolin wg. The four pSilencer 3.1-shRNA expressing vectors were transfected into Hca-F cells respectively using Lipofectamine 2000 according to the manufacturer,s interfering. For RT-PCR analysis of gelsolin mRNA levels, total RNA was isolated from cells using Trizol and cDNA was synthesized using RT-PCR Kit .PCR analysis was performed. Total cell lysates were separated by SDS-PAGE and transferred to PVDF membranes, which were incubated with the indicated antibodies. Bound antibodies were visualized by ECL. And the most effective pSilencer 3.1-shRNA vector was selected based on the results of RT-PCR and Western blotting. In the end, the Hca-F cells were transfected stably with the most effective pSilencer 3.1- gelsolin- shRNA expressing vector. 3. Hca-F cells, control cells and shRNAi cells were used for next experiment. About 1×106 cells in 100μl -RPMI1640 were seeded in duplicate into each well of the 96-well culture plates, and 10μl CCK-8 was added at 24、48、72 hours respectively. After 1 h incubation at 37℃in 5% CO2, the absorbency A450 was measured . The inhibitory effect of RNAi on Hca-F cells migration in vitro was demonstrated using 24-well transwell units with 8μm pore size polycarbonate filter. cells were harvested in 100μl serum-free medium containing 0.1% BSA and added to the upper chamber. The lower chamber contained 10μg/μl FN in 500μl RPMI 1640. Cells were incubated for 24 h at 37℃, 5% CO2 incubator. At the end of incubation the cells on the upper surface of filter were completely removed by wiping with a cotton swab. Then the filters were fixed in methanol and were stained with 0.1% gentian violet. 33% acetate acid was used to wash filters. The absorbency A450 of elution solution was measured. ECM was added in upper filter when metastasis in vitro was performed .In vivo tumor metastasis assay, three group cells were inoculated into footpad of 615 mouse subcutaneously. After three weeks, the mice were killed and their lymph nodes were isolated.
Result: 1.The result of immunofluorescence showed that gelsolin protein was located at cytoplasm of hepatic cells; western blot showed that the expression of gelsolin was positive in Hca-F and Hca-P. Its expression in Hca-F cells was higher than that in Hca-P cells﹙P<0.05﹚. 2. The recombinant vectors were confirmed by enzyme digestion analysis and DNA sequencing.The shRNA expressing recombinants were transfected into Hca-F cells successfully. Gelsolin transcript (gelsolin1,gelsolin2,gelsolin3) was reduced by 46.8%、48.2%、20.2% respectively, and the protein of GSN was reduced by 73.9%、45.1%、31.2% respectively. shRNA-1 was found to have the best effect against gelsolin protein expression(P<0.01).Hca-F cell line with gelsolin stably down regulated using shRNA technique was successfully established, which laid a favorable foundation on the gene function study of gelsolin. 3. There was no influence of gelsolin to the proliferation of hepatic cells. In vitro transwell migration , the absorbency A450 of elution solution from Hca-F cells was(0.2480±0.0447), control cells (0.2239±0.0274) to shRNAi cells (0.1716±0.0232)(P<0.05) ; In vitro invasion assay the absorbency A450 of elution solution from Hca-F cells (0.2007±0.0129), control cells (0.2236±0.0446)to shRNAi cells (0.1557±0.0051)(P<0.05) ;In vivo tumor metastasis assay, lymph node metastasis rates of Hca-F cells and control cells was 90% and 80%; lymph node metastasis rates of shRNAi cells was 50%.
Conclusion: 1.The expression of gelsolin was higher in Hca-F cells than that in Hca-P cells. 2. Hca-F cell lines with gelsolin stably down- regulated using shRNA technique was successfully established. 3. The ability of metastasis and invasion of mouse hepatocarcinoma ascites cell lines Hca-F was reduced by gelsolin after its down-regulation and proved that gelsolin played an important role in process of lymphatic metastasis of hepatocarcinoma.
本组前期利用基因芯片技术,比较Hca-F细胞和Hca-P细胞之间差异性基因的表达情况,其中gelsolin基因在Hca-F细胞中的表达是Hca-P细胞表达的21.9倍。然而蛋白质是生命活动的体现者,可以说是执行者;基因对性状的控制,是通过控制蛋白质的合成来实现的,因此基因的功能还需要在蛋白水平予以进一步检验和确认。所以我们又通过荧光差异双向凝胶电泳技术,建立了高低淋巴道转移力小鼠肝癌细胞荧光差异蛋白表达图谱,高通量筛选与肿瘤淋巴道转移相关的蛋白质,gelsolin蛋白在Hca-F细胞中的表达是在Hca-P细胞表达的1.7倍,提示其在肝癌的淋巴道转移中发挥着一定的作用。肝癌的淋巴道转移是一个多基因多步骤的过程,研究gelsolin在淋巴道转移过程中的作用和地位,有利于研究肝癌淋巴道转移机制和治疗。
目的:1.从蛋白质水平上比较蛋白质组学筛出的差异蛋白gelsolin在淋巴道转移潜能不同小鼠肝癌细胞系中的表达。2.构建pSilencer-gelsolin-shRNA表达载体,稳定转染Hca-F细胞并获得gelsolin的表达水平稳定下调的Hca-F细胞株,同时建立稳定转染pSilencer-无关序列Hca-F细胞株作为对照。3.研究gelsolin在细胞内的表达和下调其在Hca-F细胞株的表达对小鼠肝癌细胞株Hca-F在细胞增殖、细胞迁移和侵袭能力方面的影响,由此确定gelsolin与小鼠肝癌细胞淋巴道转移潜能间的关系。
方法:1.采用细胞免疫组化、蛋白免疫印迹方法检测gelsolin蛋白在Hca-F、Hca-P细胞株中表达有无差异,为进一步研究肝癌淋巴道转移的机制奠定基础。2.依据GeneBank中小鼠gelsolin基因序列(序列登录号:NM_227753)合成三条shRNA的DNA模板的两条单链,分别命名为gelsolin1、gelsolin2、gelsolin3和gelsolin无关序列,将pSilencer ?3.1-H1neo质粒双酶切后分别与三条shRNA的DNA模板和无关序列的退火后产物连接,连接产物分别命名为pSilencer-shRNA-gelsolin-1、pSilencer-shRNA-gelsolin-2、pSilencer-shRNA-gelsolin-3、pSilencer- shRNA-wg。对三条pSilencer-shRNA表达载体经测序鉴定准确后(引物为5'-GTTTTCCCAGTCACGAC-3'),将三条pSilencer-shRNA表达载体和无关序列对照组分别以脂质体法稳定转染Hca-F细胞,用含400μg/mlG418的完全培养基筛选,获得pSilencer-shRNA-gelsolin表达载体稳定转染的Hca-F细胞和无关序列对照组细胞。提取未处理的Hca-F细胞株、稳转pSilencer无关序列的Hca-F细胞株、稳pSilencer- gelsolin-shRNA三条表达载体的Hca-F细胞株的RNA、蛋白,RT-PCR和Western-Blotting检测shRNA转染后Hca-F细胞gelsolin在mRNA和蛋白质水平的表达。选出下调效果最好的一组细胞株用于后续实验。3.以三组细胞(分别为未处理的Hca-F细胞株、稳染了pSilencer无关序列的Hca-F细胞株、稳转pSilencer-shRNA-gelsolin-1表达载体的Hca-F细胞株)为实验对象。以CCK-8法检测三组细胞的细胞活力和分裂增殖能力;Transwell实验检测三组细胞的体外迁移能力(Transwell小室不做处理)、和侵袭能力(在Transwell上室中加人工基底膜);分别在615小鼠足垫内侧接种三组细胞,2×106个/0.05ml细胞,28天后观察各组淋巴结肿瘤转移情况。
结果:1.Gelsolin在小鼠腹水型肝癌细胞系Hca-F细胞和Hca-P细胞胞浆中表达,Western-blot分析显示gelsolin在Hca-F细胞中高表达,在Hca-P细胞中表达较低(P<0.05)。2.经酶切电泳分析及DNA测序鉴定,成功构建三条重组质粒,并转入Hca-F细胞;与未作处理的Hca-F细胞相比三组重组质粒gelsolin在mRNA水平的抑制率分别为46.8%、48.2%、20%;在蛋白水平对gelsolin的抑制率分别为76.4%、50.4%、37.4%;其中pSilencer-gelsolin-shRNA-1稳定转染的Hca-F细胞株gelsolin下调效果最明显(P<0.01),选择作为后续功能实验研究的gelsolin稳定下调的细胞株。3.CCK-8检测细胞增殖活性显示gelsolin不影响细胞的增殖;体外迁移实验,通过比较穿过膜的细胞在A570吸光值由Hca-F的(0.2480±0.0447)、对照组的(0.2239±0.0274)减少到干扰组细胞(0.1716±0.0232)(P<0.05);体外侵袭实验,比较穿过人工基地膜Hca-F细胞(0.2007±0.0129)、对照组(0.2236±0.0446)和干扰组细胞(0.1557±0.0051),可以发现下调gelsolin蛋白表达后,干扰组细胞穿过人工基底膜的细胞A570 OD值吸光度值较对照降低(P<0.05),结果显示下调Hca-F细胞中gelsolin的表达后,转移的肿瘤细胞数量减少,癌细胞的运动侵袭能力下降;体内淋巴结转移实验显示,下调gelsolin抑制了Hca-F细胞在小鼠体内淋巴结的转移率。
结论:1.Gelsolin在小鼠腹水型肝癌细胞系Hca-F和Hca-P均有表达,且Hca-F中较高,而在Hca-P中表达较低。2.利用pSilencer?3.1-H1neo质粒和shRNA成功构建了三个pSilencer-gelsolin-shRNA表达载体,该载体转染Hca-F细胞细胞后,经含有400μg/mlG418的完全培养基筛选,获得了稳定转染pSilencer-gelsolin-shRNA表达载体的Hca-F细胞株,在成功构建的shRNA稳定转染的Hca-F细胞中,其中pSilencer- gelsolin-shRNA-1对Hca-F细胞中gelsolin抑制效果最明显,作为后续研究的细胞株。3.Gelsolin具有增强肿瘤细胞迁移和侵袭的能力,抑制gelsolin基因和蛋白的表达,具有下调鼠源肝癌细胞转移和侵袭能力的作用,证明在肝癌的淋巴道转移过程中gelsolin发挥着重要的作用。
Background: Many biological processes, such as embryonic morpho- genesis, immune surveillance, and tissue repair and regeneration, are required for cell migration which drives progression of many diseases, including cancer invasion and metastasis.
Cell migration is a highly integrated multistep process which is initiated by the protrusion of cell membrane. In the process of tumor invasion and metastasis, the relationship among tumor cell,host cell and extracellular matrix (ECM) is complicated. The actin cytoskeleton is crucial for cell motility, and it connects with cell disintegration, cell differentiation, apoptosis and canceration. Gelsolin is best known for its involvement in dynamic changes in the actin cytoskeleton during a variety of forms of cell motility.
Hca-P and Hca-F is a pair of syngenetic mouse hepatocarcinoma ascites cell lines, presenting a specific potential of lymphatic metastasis when inoculated subcutaneously in 615 mice. Hca-F with a high metastasis potential (>70%) and Hca-P with a low one (<30%) are rare and available cell model as a control to each other in the research on the molecular mechanisms of lymphatic metastasis.
Based on the gene chip experiment, we found that the expression of gelsolin in Hca-F cells was higher than that in Hca-P cells (21.9 fold compared with Hca-P cells). In order to obtain lymphatic metastasis associated proteins, the protein expressed profiles of Hca-F cells and Hca-P cells were compared using fluorescent two-dimensional difference gel electrophoresis (2D DIGE).Gelsolin protein was up-regulated in Hca-F cells (1.7 fold compared with Hca-P cells) . It was suggestted that gelsolin was a lymph node metastasis-associated protein.
Objective: 1. To observed the expression of gelsolin in Hca-F cells and Hca-P cells. 2. Down-regulating the gelsolin expression in Hca-F cells by using pSilencer 3.1-shRNA expressing vectors. 3. To investigate the effect of gelsolin on the proliferation and invasion of mouse hepatocarcinoma cell lines.
Method:1. Immunohistochemistry and western blot were utilized to show the expression of gelsolin in Hca-F cells and Hca-P cells. 2. Three shRNAs and scrambled shRNA sequences were designed and synthesized according to gelsolin gene sequences .Then three shRNAs and scrambled shRNA sequences were inserted into the pSilencer-3.1 vector to silence gelsolin gene ,and named gelsolin1、gelsolin2、gelsolin3 and gelsolin wg. The four pSilencer 3.1-shRNA expressing vectors were transfected into Hca-F cells respectively using Lipofectamine 2000 according to the manufacturer,s interfering. For RT-PCR analysis of gelsolin mRNA levels, total RNA was isolated from cells using Trizol and cDNA was synthesized using RT-PCR Kit .PCR analysis was performed. Total cell lysates were separated by SDS-PAGE and transferred to PVDF membranes, which were incubated with the indicated antibodies. Bound antibodies were visualized by ECL. And the most effective pSilencer 3.1-shRNA vector was selected based on the results of RT-PCR and Western blotting. In the end, the Hca-F cells were transfected stably with the most effective pSilencer 3.1- gelsolin- shRNA expressing vector. 3. Hca-F cells, control cells and shRNAi cells were used for next experiment. About 1×106 cells in 100μl -RPMI1640 were seeded in duplicate into each well of the 96-well culture plates, and 10μl CCK-8 was added at 24、48、72 hours respectively. After 1 h incubation at 37℃in 5% CO2, the absorbency A450 was measured . The inhibitory effect of RNAi on Hca-F cells migration in vitro was demonstrated using 24-well transwell units with 8μm pore size polycarbonate filter. cells were harvested in 100μl serum-free medium containing 0.1% BSA and added to the upper chamber. The lower chamber contained 10μg/μl FN in 500μl RPMI 1640. Cells were incubated for 24 h at 37℃, 5% CO2 incubator. At the end of incubation the cells on the upper surface of filter were completely removed by wiping with a cotton swab. Then the filters were fixed in methanol and were stained with 0.1% gentian violet. 33% acetate acid was used to wash filters. The absorbency A450 of elution solution was measured. ECM was added in upper filter when metastasis in vitro was performed .In vivo tumor metastasis assay, three group cells were inoculated into footpad of 615 mouse subcutaneously. After three weeks, the mice were killed and their lymph nodes were isolated.
Result: 1.The result of immunofluorescence showed that gelsolin protein was located at cytoplasm of hepatic cells; western blot showed that the expression of gelsolin was positive in Hca-F and Hca-P. Its expression in Hca-F cells was higher than that in Hca-P cells﹙P<0.05﹚. 2. The recombinant vectors were confirmed by enzyme digestion analysis and DNA sequencing.The shRNA expressing recombinants were transfected into Hca-F cells successfully. Gelsolin transcript (gelsolin1,gelsolin2,gelsolin3) was reduced by 46.8%、48.2%、20.2% respectively, and the protein of GSN was reduced by 73.9%、45.1%、31.2% respectively. shRNA-1 was found to have the best effect against gelsolin protein expression(P<0.01).Hca-F cell line with gelsolin stably down regulated using shRNA technique was successfully established, which laid a favorable foundation on the gene function study of gelsolin. 3. There was no influence of gelsolin to the proliferation of hepatic cells. In vitro transwell migration , the absorbency A450 of elution solution from Hca-F cells was(0.2480±0.0447), control cells (0.2239±0.0274) to shRNAi cells (0.1716±0.0232)(P<0.05) ; In vitro invasion assay the absorbency A450 of elution solution from Hca-F cells (0.2007±0.0129), control cells (0.2236±0.0446)to shRNAi cells (0.1557±0.0051)(P<0.05) ;In vivo tumor metastasis assay, lymph node metastasis rates of Hca-F cells and control cells was 90% and 80%; lymph node metastasis rates of shRNAi cells was 50%.
Conclusion: 1.The expression of gelsolin was higher in Hca-F cells than that in Hca-P cells. 2. Hca-F cell lines with gelsolin stably down- regulated using shRNA technique was successfully established. 3. The ability of metastasis and invasion of mouse hepatocarcinoma ascites cell lines Hca-F was reduced by gelsolin after its down-regulation and proved that gelsolin played an important role in process of lymphatic metastasis of hepatocarcinoma.
引文
1. DingyiWen, Karen Corina, E. Pingchang Chow, Stephan Miller, Paul A Janmey,R Blake Pepinsky. The plasma and cytoplasmic forms of human gelsolin differ in disulfide structure. Biochemistry 1996 Jul; 35(30):9700-9709.
2. Silacci P, Mazzolai L,Gauci C,Stergiopulos N,Yin HL,Hayoz D.Gelsolin superfamily proteins: key regulators of cellular functions .Cell Mol Life Sci 2004 Oct;61(19-20):2614-2623.
3. Sun HQ, Yamamoto M, Mejillano M, Yin HL. Gelsolin, a multifunctional actin regulatory protein. J Biol Chem 1999 Nov; 274(47):33179-33182.
4. Hartwig JH. Machanisms of actin rearrangements mediating paltelaet activation. Cell Biol 1992 Sep; 118(6):1421–1442.
5. Kwiatkowski DP, Stossel TP, Orkin SH, Mole JE, Colten HR, Yin HL. Plasma and cytoplasmic gelsolins are encoded by s single gene and contain a duplicated actin-bingding domain.Nature 1986 Oct; 323(6087):455-458.
6. Burtnick LD, Koepf EK, Grimes J, Jones EY, Stuart DI, McLaughlin, PJ, Robinson RC.The crystal structure of plasma gelsolin:implications for actin sneering、capping、and nucleation. Cell 1997 Aug; 90(4):661-670.
7. McLaughlin PJ, Gooch JT,Mannherz HG,Weeds AG.Structure of gelsolin segment 1-actin complex and the mechanism filament severing .Nature 1993 Aug;364: 685-692.
8. McGough A, Chiu W, Way M. Determination of the gelolin binding site on F-actin: implications for severing and capping. Biophys J 1998 Feb; 74(2 Pt 1): 764-772.
9. Yin HL, Zaner KS, Stossel TP. Ca2+ control of actin gelation. Interaction of gelsolin with actin filaments and regulation of actin gelation. Biol Chem, 1980 Oct; 255(19):9494-9500.
10. Weeds AG, Gooch J, McLaughlin P, Pope B, Bengtsdotter M, Karlsson R. Identification of the trapped calcium in the gelsolin segment 1-actin complex: implications for the role of calcium in the control of gelsolin activity. FEBS Lett 1995 Mar;360(3):227-230.
11. Gremm D, Wegner A. Co-operative binding of Ca2+ ions to the regulatory binding sites of gelsolin. Eur J Biochem 1999 Jun; 262(2):330-334.
12. Kwiatkowski DP, Janmey PA, Yin HL. Identification of critical functional andregulatory domains in gelsolin.J Cell Biol 1989 May; 108(5):1717-1726.
13. Koepf EK, Burtnick LD. Multiple pathways for denaturation of horse plasma gelsolin. Biochem Cell Biol 1996; 74(1):101-107.
14. Yu FX, Sun HQ, Janmey PA,Yin HL.Identification of a polyphosphoinositide - binding sequence in an actin monomer-binding domain of gelsolin.J Biol Chem 1992 Jul;267(21):14616-14621.
15. Pope BJ, Gooch JT, Weeds AG. Probing the effects of calcium on gelsolin. Bio- chemistry 1997 Dec; 36(50):15848-15855.
16. Lin KM, Wenegieme EF, Lu PJ, Chen, CS, Yin, HL. Gelsolin binding to phosph- atidylinositol 4, 5-bisphosphate is modulated by calcium and Ph J Biol Chem. 1997 Aug;272(33):20443-20450.
17. Tuominen EKJ, Holopainen JM, Chen J, Prestwich GD. Bachiller PR, Kinnunen PKJ,Janmey PA.Polymorphic forms of human ADP-ribosyltransferase-1 dif- ferences in their catalytic activities revealed by labeling of membrane- associated substrates .Eur J Biochem 1999 Jun; 262(2):1-9.
18. Flanagan LA, Cunningham CC, Chen J, Prestwich GD, Kosik KS, Janmey PA. The structure of divalent cation-induced aggregates of PIP2 and their alteration by gelsolin and tau .Biophys 1997 Sep; 73(3):1440-1447.
19. Azuma T, Witke W, Stossel TP, Hartwig JH, Kwiatkowski DJ. Gelsolin is a downstream effector of Rac for fibroblast motility.EMBO J 1998 Mar; 17(5): 1362-1370.
20. Laine RO, Phaneuf KL, Cunningham CC, Kwiatkowski D, Azuma T, Southwick FS.Gelsolin, a protein that caps the barbed ends and severs actin filaments, enhances the actin-based motility of Listeria monocytogenes in host cells .Infect Immun 1998 Aug; 66(8):3775-3782.
21. Chen P, Murphy-Ullrich JE, Wells A.A role for gelsolin in actuatingepidermal growth factor receptor-mediated cell motility. J Cell Biol 1996 Aug; 134 (3):689- 698.
22. Chellaiah M, Kizer N, Silva M, Alvarez U, Kwiatkowski D, Hruska KA .Gelsolin deficiency blocks podosome assembly and produces increased bone mass and strength .J Cell Biol 2000 Feb;148(4):665-678.
23. Arcaro A. The small GTP-binding protein Rac promotes the dissociation of gelsolin from actin filaments in neutrophils.BiolChem 1998 Jan; 273(2):805-813.
24. Barkalow K, Witke W, Kwiatkowski DJ, Hartwig JH. Coordinated regulation ofplatelet actin filament barbed ends by gelsolin and capping protein. J Cell Biol 1996 Jul; 134(2):389-399.
25. Furukawa K, Fu W, Li Y, Witke W, Kwiatkowski DJ, Mattson MP. The actin-severing protein gelsolin modulates calcium channel and NMDA receptor activities and vulnerability to excitotoxicity in hippocampal neurons. J Neurosci. 1997 Nov; 17(21):8178-8186.
26. De Corte V, Bruyneel E, Boucherie C, Mareel M, Vandekerckhove J, Gettemans J.Gelsolin-induced epithelial cell invasion is dependent on Ras-Rac signaling. EMBO 2002 Dec; 21(24):6781-6790.
27. Dong Y, Asch HL, Medina D, Ip C, Ip M, Guzman R, Asch BB. Concurrent dere- gulation of gelsolin and cyclin D1 in the majority of human and rodent breast ca- ncers. Int J Cancer 1999 Jun; 81(6):930-938.
28. Sj?blom T, Jones S, Wood LD, Parsons DW, Lin J. The consensus coding sequences of human breast and colorectal cancers.Science 2006 Oct; 314 (5797): 268-274.
29. Dong Y, Asch HL, Ying A, Asch BB. Molecularmechanism of transcriptional repression of gelsolin in human breast cancer cells. ExpCell Res 2002 Jun; 276 (2): 328-336.
30.倪晓光,王贵齐,白晓枫,刘芳,周兰萍,赵平.泛素-蛋白酶体途径降解胰腺癌细胞系中凝溶胶蛋白.基础医学与临床2008 Jun;28(6):535-538.
31. Asch HL, Winston JS, Edge SB, Stomper PC, Asch BB. Downregulation of gelsolin expression in human breast ductal carcinoma in situ with and without invasion. Breast Cancer Res Treat 1999 May; 55(2):179-188.
32. Gay F, Estornes Y, Saurin JC, Joly-Pharaboz MO, Friederich E, Scoazec JY, Abello J. In colon carcinogenesis, the cytoskeletal protein gelsolin is down- regulated during the transition from adenoma to carcinoma .Hum Pathol 2008 Oct; 39 (10):1420-1430.
33. Lee HK, Driscoll D, Asch H, Asch B, Zhang PJ. Downregulated gelsolin expres- sion in hyperplastic and neoplastic lesions of the prostate. Prostate 1999 Jun; 40 (1):14-19.
34. Shieh DB, Chen IW, Wei TY, Shao CY, Chang HJ, Chung CH, Wong TY, Jin YT. Tissue expression of gelsolin in oral carcinogenesis progression and its clinic- pathological implications. Oral Oncology 2006 Jul; 42 (6):599-606.
35. Shieh DB, Godleski J, Herndon JE 2nd, Azuma T, Mercer H, Sugarbaker DJ, Kw-iatkowski DJ.Cell motility as a prognostic factor in stageⅠnonsmall cell lung carcinoma: the role of gelsolin expression . Cancer 1999 Jan; 85(1):47-57.
36. Liu S, Sun MZ, Tang JW, Wang Z, Sun C, Greenaway FT. High -performance liquid chromatography/nanoelectrospray ionization tandem mass spectrometry, two-dimensional difference in-gel electrophoresis and gene microarray identify- cation of lymphatic metastasis-associated biomarkers. R C M, 2008 Oct; 22 (20): 3172-3178.
37.孙成荣,唐建武,孙明忠,刘淑清,张宏颖,王波,宋波,张亚楠,张竹清,赵志英.采用定量蛋白质组学技术筛选小鼠肝癌淋巴道转移相关蛋白.生物化学与生物物理进展. 2007 Mar; 4 (8): 856-864.
38. Song B, Tang JW, Wang B, et al. Screening for lymphatic metastasis-associated genes in mouse hepatocarcinoma cell lines Hca-F and Hca-P using gene chip .癌症2005 Jul; 24(7):774-780.
39. Walsh N, Dowling P, O'Donovan N, Henry M, Meleady P, Clynes M.Aldehyde dehydrogenase 1A1 and gelsolin identified as novel invasion-modulating factors in conditioned medium of pancreatic cancer cells. Proteomics 2008 Dec; 71 (5):561-571.
40. Koya RC, Fujita H, Shimizu S, Ohtsu M, Takimoto M, Tsujimoto Y, Kuzumaki N. Gelsolin inhibits apoptosis by blocking mitochondrial membrane potential loss and cytochromec release.Biol Chem 2000 Aug; 275(20):15343-15349.
41. Ohtsu M, Sakai N, Fujita H, Kashiwagi M, Gasa S, Shimizu S, Eguchi Y, Tsujim- oto Y, Sakiyama Y, Kobayashi K, Kuzumaki N.Inhibition of apoptosis by the actin-regulatory protein gelsolin. EMBO 1997 Aug; 16(15):4650-4656.
42. Klampfer L, Huang J, Sasazuki T,Shirasawa S, Augenlicht L. Oncogenic Ras promotes butyrate-induced apoptosis through Inhibition of gelsolin expression . J Biol Chem 2004 Aug; 279(35):36680-36688.
43. Garcia CD, Knock E, Jabado N, Rozen R. Intestinal neoplasia induced by low dietary folate is associated with altered tumor expression profiles and decreased apoptosis in mouse normal intestine. J Nutr 2009 Mar; 139(3):488-494.
44. Endres M, Fink K, Zhu J, Stagliano NE, Bondada V, Geddes JW, Azuma T, Mattson MP, Kwiatkowski DJ, Moskowitz MA.Neuroprotective effects of gelsolin during murine stroke.JClinInvest 1999 Feb;103(3):3472-354
1. Nabeshima K, Inoue T, Shimao Y, Kataoka H, Koono M.Cohort migration of carcinoma cells: differentiated colorectal carcinoma cells move as coherent cell clusters or sheets. Histol Histopathol 1999 Oct; 14(4):1183-1197.
2. Song B, Tang JW, Wang B, Cui XN, Hou L, Sun L, Mao LM, Zhou CH, Du Y, Wang LH, Wang HX, Zheng RS, Sun L. Identify lymphatic metastasis2associated genes in mouse hepatocarcinoma cell lines using gene chip. World J Gast- roenterol 2005 Mar; 11(10):1463-1472.
3.孙成荣,唐建武,孙明忠,刘淑清,张宏颖,王波,宋波,张亚楠,张竹清,赵志英.采用定量蛋白质组学技术筛选小鼠肝癌淋巴道转移相关蛋白.生物化学与生物物理进展2007, 34 (8): 856-864.
4. Liu SQ, Sun MZ, Tang JW, Wang Z, Sun CR, Greenaway FT. High-performance liquid chromatography/nanoelectrospray ionization tandem mass spectrometry, two-dimensional difference in-gel electrophoresis and gene microarray iden- tification of lymphatic metastasis-associated biomarkers. RCM 2008, 22 (8): 3172-3178.
5.凌茂英,王明辉,郭伶伶,王波. Hca/ 16A32F及Hca/ A22P两株小鼠淋巴道转移肝癌细胞系的特性研究.中华医学杂志.1995 Mar ;75 (3):170-171.
6. Yamaguchi H., Condeelis J. Regμlation of the actin cytoskeleton in cancer cell migration and invasion. Biochim Biophys Acta 2007 May; 1117 (5): 642-652.
7. Tanaka M, Müllauer L, Ogiso Y, Fujita H, Moriya S, Furuuchi K, Harabayashi T, Shinohara N, Koyanagi T, Kuzumaki N. Gelsolin: A Candidate for Suppressor of Human Bladder Cancer .Cancerresearch 1995 Aug; 55 (8 ): 3228-3232.
8. Rao J,Seligson D,Visapaa H,Horvath S, Eeva M, Michel K, Pantuck A, Belldegrun A, Palotie A. Tissue microarray analysis of cytoskeletal actin- associated biomarkers gelsolin and E-cadherin in urothelial carcinoma. Cancer 2002 Sep; 95 (4): 1247-1257.
9. Thor AD, Edgerton SM, Liu S, Moore DH 2nd, Kwiatkowski DJ. Gelsolin as a negative prognostic factor and effector of motility in erbB-positive epidermal growth factor receptor-positive breast cancers .Clin Cancer Res .2001 Aug; 7 (8): 2415-2424.
10. Yang J, Ramnath N, Moysich KB, Asch HL, Swede H, Alrawi SJ, Huberman J, Geradts J, Brooks JS, Tan D. Prognostic significance of MCM2, Ki-67 andgelsolin in non-small cell lung cancer.BMC Cancer 2006 Aug; 203(6): 1-10.
11. Hou L, Li Y, Jia YH, Wang B, Xin Y, Ling MY, LüS. Molecμlar mechanism about lympho genous metastasis of hepatocarcinoma cells in mice. World J Gastr- oenterol 2001 Aug;7(4):532-536.
12. Van dA A, De CV, Van IK, Bruyneel E, Boucherie C, Bracke M, Vandekerckhove J, Gettemans J .Downregulation of Gelsolin family proteins counteracts cancer cell invasion in vitro .Cancer Letters 2007 Sep; 255(1):57-70.
13.史伟峰,陈同钰,鲁常青,谈敏,谈炎,张学光.Gelsolin分子在乳腺癌中的表达.肿瘤2002 Jul;3(4):289-293.
14. Shieh DB, Godleski J, Herndon JE 2nd, Azuma T, Mercer H, Sugarbaker DJ, Kwiatkowski DJ. Cell motility as a prognostic factor in stageⅠnonsmall cell lung carcinoma: the role of gelsolin expression. Cancer 1999 Jan; 85(1):47-57.
1.凌茂英,王明辉,郭伶伶,王波. Hca/ 16A32F及Hca/ A22P两株小鼠淋巴道转移肝癌细胞系的特性研究.中华医学杂志1995 Mar;75 (3):170-171.
2. Song B, Tang JW, Wang B, Cui XN, Hou L, Sun L, Mao LM, Zhou CH, Du Y, Wang LH, Wang HX, Zheng RS, Sun L. Identify lymphatic metastasis2associated genes in mouse hepatocarcinoma cell lines using gene chip. World J Gastroenterol 2005 Mar; 11(10):1463-1472.
3.孙成荣,唐建武,孙明忠,刘淑清,张宏颖,王波,宋波,张亚楠,张竹清,赵志英.采用定量蛋白质组学技术筛选小鼠肝癌淋巴道转移相关蛋白.生物化学与生物物理进展2007 Mar;4 (8): 856-864.
4. Liu SQ, Sun MZ, Tang JW, Wang Z, Sun CR, Greenaway FT. High-performance liquid chromatography/nanoelectrospray ionization tandem mass spectrometry, two-dimensional difference in-gel electrophoresis and gene microarray identi- fication of lymphatic metastasis-associated biomarkers. RCM 2008 Oct; 22(20): 3172-3178.
5. H Yamaguchi, J Condeelis. Regulation of the actin cytoskeleton in cancer cell migration and invasion.Biochim Biophys Acta. 2007 May; 1773 (5): 642 - 652.
6. McGough AM, Staiger CJ, Min JK, Simonetti KD. The gelsolin family actin regulatory proteins: modular structures, versatile functions. FEBS Letters 2003 Sep 25; 552(2-3):75-81.
7. Dirk G, Mark A K. Therapeutic application of RNAi: is mRNA targeting finally ready for prime time? J Clin Invest 2007 Dec; 117(12):3633-3641.
8. Nathanson S D. Insights into the mechanisms of lymph node metastasis. Cancer 2003 Jul 15; 98(2):413-423.
9. Van AA, De CV, Van IK, Bruyneel E, Boucherie C, Bracke M, Vandekerckhove J, Gettemans J .Downregulation of gelsolin family proteins counteracts cancer cell invasion in vitro .Cancer Letters 2007 Sep;25 (1):57-70.
10. Shieh DB, Godleski J, Herndon JE 2nd, Azuma T, Mercer H, Sugarbaker DJ, Kwiatkowski DJ. Cell motility as a prognostic factor in stageⅠnonsmall cell lung carcinoma: the role of gelsolin expression. Cancer 1999 Jan; 85 (1):47-57.
11. Lee NS, Dohjima T, Bauer G, Li H, Li MJ, Ehsani A, Salvaterra P, Rossi J. Ex- pression of small interfering RNAs targeted against HIV- 1 rev transcripts in human cells. Nat Biotechnol 2002 May; 20(5):500-505.
12. Angell SM, Banlcombe DC. Angell SM, Baμlcombe DC. Consistent gene silencing in transgenic plants expressing a replicating potato virus X RNA. EMBO J 1997 Jun; 16(12):3675-3684.
1.凌茂英,王明辉,郭伶伶,王波. Hca/ 16A32F及Hca/ A22P两株小鼠淋巴道转移肝癌细胞系的特性研究.中华医学杂志, 1995 Mar;75 (3): 170 - 171.
2. Cui XN, Tang JW, Hou L, Song B, Ban LY. Identification of differentially expressed genes in mouse hepatocarcinoma ascites cell line with low potential of lymphogenous metastasis. World J Gastroenterol. 2006 Nov;12(42):6893-6897.
3. Song B, Tang JW, Wang B, Cui XN, Hou L, Sun L, Mao LM, Zhou CH, Du Y, Wang LH, Wang HX, Zheng RS, Sun L. Identify lymphatic metastasis2associated genes in mouse hepatocarcinoma cell lines using gene chip. World J Gast roenterol 2005 Mar; 11(10):1463-1472.
4. Liu SQ, Sun MZ, Tang JW, Wang Z, Sun CR, Greenaway FT. High-performance liquid chromatography/nanoelectrospray ionization tandem mass spectrometry, two-dimensional difference in-gel electrophoresis and gene microarray identify- cation of lymphatic metastasis-associated biomarkers. RCM 2008 Oct; 22(20): 3172-3178.
5. McGough AM, Staiger CJ, Min JK, Simonetti KD. The gelsolin family actin regulatory proteins: modular structures, versatile functions. FEBS Letters 2003 Sep 25; 552(2-3):75-81.
6. Rao J, Seligson D, Visapaa H, Horvath S, Eeva M, Michel K, Pantuck A, Belldegrun A, Palotie A. Tissue microarray analysis of cytoskeletal actin- associated biomarkers gelsolin and E-cadherin in urothelial carcinoma . Cancer 2002 Sep; 95(6):1247-1257.
7. Shieh DB, Godleski J, Herndon JE 2nd, Azuma T, Mercer H, Sugarbaker DJ, Kwiatkowski DJ. Cell motility as a prognostic factor in stageⅠnonsmall cell lung carcinoma: the role of gelsolin expression . Cancer 1999 Jan; 85(1):47-57.
8. Hou G, Xue L, Lu Z, Fan T, Tian F, Xue Y. An activated Mtor/p70S6K singaling pathway in esophageal squamous cell carcinoma cell lines and inhibitioan of the pathway by rapamycin and siRNAs gainst mTOR. Cancer Lett 2007 Aug; 253(2): 236-248.
9.高进,章静波.癌的侵袭与转移基础与临床.1996 Mar.
10. Kim CS, Furuya F, Ying H, Kato Y, Hanover JA, Cheng SY. Gelsolin: a novel thyroid hormone receptor-beta interacting protein that modulates tumor progr- ession in a mouse model of follicular thyroid cancer. Endocrinology 2007 Mar;148(3):1306-1312.
11.史伟峰,陈同钰,鲁常青,谈敏,谈炎,张学光.Gelsolin分子在乳腺癌组织中的表达研究.肿瘤2002 Jul;22(4):289-293.
12. Thompson CC, Ashcroft FJ, Patel S, Saraga G, Vimalachandran D, Prime W, Campbell F, Dodson A, Jenkins RE, Lemoine NR, Crnogorac-Jurcevic T, Yin HL, Costello E. Pancreatic cancer cells overexpress gelsolin familycapping proteins which contribute to their cell motility .Gut 2007 Jan;56(1):95-106.
13. Gay F, Estornes Y, Saurin JC, Joly-Pharaboz MO, Friederich E, Scoazec JY, Abello J.In colon carcinogenesis, the cytoskeletal protein gelsolin is down- regμlated during the transition from adenoma to carcinoma .Hum Pathol 2008 Oct;39(10):1420-1430.
14. B Shieh, IW Chen, TY Wei, et al .Tissue expression of gelsolin in oral carcinogenesis progressionand its clinicopathological implications. Oral Oncol 2006 Jul; 42(6):599-606.
15. Sj?blom T, Jones S, Wood LD, Parsons DW, Lin J, Barber TD, Mandelker D, Leary RJ, Ptak J, Silliman N, Szabo S, Buckhaults P, Farrell C, Meeh P, Markowitz SD, Willis J, Dawson D, Willson JK, Gazdar AF, Hartigan J, Wu L, Liu C, Parmigiani G, Park BH, Bachman KE, Papadopoulos N, Vogelstein B, Kinzler KW, Velculescu VE.The consensus coding sequences of human breast and colorectal cancers. Science 2006 Oct; 314(5797):268-274.
16. Azuma T, Witke W, Stossel TP, Hartwig JH, Kwiatkowski DJ. Gelsolin is a downstream effector of Rac for fibroblast motility.EMBO J 1998 Mar; 17 (5): 1362-1370.
17. Laine RO, Phaneuf KL, Cunningham CC, Kwiatkowski D, Azuma T, Southwick FS.Gelsolin, a protein that caps the barbed ends and severs actin filaments, enhances the actin-based motility of Listeria monocytogenes in host cells.Infect Immun 1998 Aug;66(8):3775-3782.
18. Chen P, Murphy-Ullrich JE, Wells A.A role for gelsolin in actuating epidermal growth factor receptor-mediated cell motility.Cell Biol 1996 Aug;134(3): 689- 698.
19. Lader AS, Lee JJ, Cicchetti G, Kwiatkowski DJ. Mechanisms of gelsolin- dependent and -independent EGF-stimulated cell motility in a human lung epithelial cell line. Exp Cell Res 2005 Jul; 307(1):153-163.
20. Chellaiah M, Kizer N, Silva M, Alvarez U, Kwiatkowski D, Hruska KA .Gelsolindeficiency blocks podosome assembly and produces increased bone mass and strength. J Cell Biol 2000 Feb; 148(4):665-678.
21. Van den Abbeele A, De Corte V, Van Impe K, Bruyneel E, Boucherie C, Bracke M, Vandekerckhove J, Gettemans J .Downregμlation of gelsolin family proteins counteractscancer cell invasion in vitro .Cancer Letters 2007 Sep;255(1):57-70.
22. Koya RC, Fujita H, Shimizu S, Ohtsu M, Takimoto M, Tsujimoto Y, Kuzumaki N. Gelsolin inhibits apoptosis by blocking mitochondrial membrane potential loss and cytochromec release.Biol Chem 2000 May;275(20):15343-15349.
23. Ohtsu M, Sakai N, Fujita H, Kashiwagi M, Gasa S, Shimizu S, Eguchi Y, Tsujimoto Y, Sakiyama Y, Kobayashi K, Kuzumaki N.Inhibition of apoptosis by the actin - regulatory protein gelsolin. EMBO 1997 Aug; 16(15):4650-4656.
24. Garcia CD, Knock E, Jabado N, Rozen R. Intestinal neoplasia induced by low dietary folate is associated with altered tumor expression profiles and decreased apoptosis in mouse normal intestine. Nutr 2009 Mar; 139(3):488-494.
2. Silacci P, Mazzolai L,Gauci C,Stergiopulos N,Yin HL,Hayoz D.Gelsolin superfamily proteins: key regulators of cellular functions .Cell Mol Life Sci 2004 Oct;61(19-20):2614-2623.
3. Sun HQ, Yamamoto M, Mejillano M, Yin HL. Gelsolin, a multifunctional actin regulatory protein. J Biol Chem 1999 Nov; 274(47):33179-33182.
4. Hartwig JH. Machanisms of actin rearrangements mediating paltelaet activation. Cell Biol 1992 Sep; 118(6):1421–1442.
5. Kwiatkowski DP, Stossel TP, Orkin SH, Mole JE, Colten HR, Yin HL. Plasma and cytoplasmic gelsolins are encoded by s single gene and contain a duplicated actin-bingding domain.Nature 1986 Oct; 323(6087):455-458.
6. Burtnick LD, Koepf EK, Grimes J, Jones EY, Stuart DI, McLaughlin, PJ, Robinson RC.The crystal structure of plasma gelsolin:implications for actin sneering、capping、and nucleation. Cell 1997 Aug; 90(4):661-670.
7. McLaughlin PJ, Gooch JT,Mannherz HG,Weeds AG.Structure of gelsolin segment 1-actin complex and the mechanism filament severing .Nature 1993 Aug;364: 685-692.
8. McGough A, Chiu W, Way M. Determination of the gelolin binding site on F-actin: implications for severing and capping. Biophys J 1998 Feb; 74(2 Pt 1): 764-772.
9. Yin HL, Zaner KS, Stossel TP. Ca2+ control of actin gelation. Interaction of gelsolin with actin filaments and regulation of actin gelation. Biol Chem, 1980 Oct; 255(19):9494-9500.
10. Weeds AG, Gooch J, McLaughlin P, Pope B, Bengtsdotter M, Karlsson R. Identification of the trapped calcium in the gelsolin segment 1-actin complex: implications for the role of calcium in the control of gelsolin activity. FEBS Lett 1995 Mar;360(3):227-230.
11. Gremm D, Wegner A. Co-operative binding of Ca2+ ions to the regulatory binding sites of gelsolin. Eur J Biochem 1999 Jun; 262(2):330-334.
12. Kwiatkowski DP, Janmey PA, Yin HL. Identification of critical functional andregulatory domains in gelsolin.J Cell Biol 1989 May; 108(5):1717-1726.
13. Koepf EK, Burtnick LD. Multiple pathways for denaturation of horse plasma gelsolin. Biochem Cell Biol 1996; 74(1):101-107.
14. Yu FX, Sun HQ, Janmey PA,Yin HL.Identification of a polyphosphoinositide - binding sequence in an actin monomer-binding domain of gelsolin.J Biol Chem 1992 Jul;267(21):14616-14621.
15. Pope BJ, Gooch JT, Weeds AG. Probing the effects of calcium on gelsolin. Bio- chemistry 1997 Dec; 36(50):15848-15855.
16. Lin KM, Wenegieme EF, Lu PJ, Chen, CS, Yin, HL. Gelsolin binding to phosph- atidylinositol 4, 5-bisphosphate is modulated by calcium and Ph J Biol Chem. 1997 Aug;272(33):20443-20450.
17. Tuominen EKJ, Holopainen JM, Chen J, Prestwich GD. Bachiller PR, Kinnunen PKJ,Janmey PA.Polymorphic forms of human ADP-ribosyltransferase-1 dif- ferences in their catalytic activities revealed by labeling of membrane- associated substrates .Eur J Biochem 1999 Jun; 262(2):1-9.
18. Flanagan LA, Cunningham CC, Chen J, Prestwich GD, Kosik KS, Janmey PA. The structure of divalent cation-induced aggregates of PIP2 and their alteration by gelsolin and tau .Biophys 1997 Sep; 73(3):1440-1447.
19. Azuma T, Witke W, Stossel TP, Hartwig JH, Kwiatkowski DJ. Gelsolin is a downstream effector of Rac for fibroblast motility.EMBO J 1998 Mar; 17(5): 1362-1370.
20. Laine RO, Phaneuf KL, Cunningham CC, Kwiatkowski D, Azuma T, Southwick FS.Gelsolin, a protein that caps the barbed ends and severs actin filaments, enhances the actin-based motility of Listeria monocytogenes in host cells .Infect Immun 1998 Aug; 66(8):3775-3782.
21. Chen P, Murphy-Ullrich JE, Wells A.A role for gelsolin in actuatingepidermal growth factor receptor-mediated cell motility. J Cell Biol 1996 Aug; 134 (3):689- 698.
22. Chellaiah M, Kizer N, Silva M, Alvarez U, Kwiatkowski D, Hruska KA .Gelsolin deficiency blocks podosome assembly and produces increased bone mass and strength .J Cell Biol 2000 Feb;148(4):665-678.
23. Arcaro A. The small GTP-binding protein Rac promotes the dissociation of gelsolin from actin filaments in neutrophils.BiolChem 1998 Jan; 273(2):805-813.
24. Barkalow K, Witke W, Kwiatkowski DJ, Hartwig JH. Coordinated regulation ofplatelet actin filament barbed ends by gelsolin and capping protein. J Cell Biol 1996 Jul; 134(2):389-399.
25. Furukawa K, Fu W, Li Y, Witke W, Kwiatkowski DJ, Mattson MP. The actin-severing protein gelsolin modulates calcium channel and NMDA receptor activities and vulnerability to excitotoxicity in hippocampal neurons. J Neurosci. 1997 Nov; 17(21):8178-8186.
26. De Corte V, Bruyneel E, Boucherie C, Mareel M, Vandekerckhove J, Gettemans J.Gelsolin-induced epithelial cell invasion is dependent on Ras-Rac signaling. EMBO 2002 Dec; 21(24):6781-6790.
27. Dong Y, Asch HL, Medina D, Ip C, Ip M, Guzman R, Asch BB. Concurrent dere- gulation of gelsolin and cyclin D1 in the majority of human and rodent breast ca- ncers. Int J Cancer 1999 Jun; 81(6):930-938.
28. Sj?blom T, Jones S, Wood LD, Parsons DW, Lin J. The consensus coding sequences of human breast and colorectal cancers.Science 2006 Oct; 314 (5797): 268-274.
29. Dong Y, Asch HL, Ying A, Asch BB. Molecularmechanism of transcriptional repression of gelsolin in human breast cancer cells. ExpCell Res 2002 Jun; 276 (2): 328-336.
30.倪晓光,王贵齐,白晓枫,刘芳,周兰萍,赵平.泛素-蛋白酶体途径降解胰腺癌细胞系中凝溶胶蛋白.基础医学与临床2008 Jun;28(6):535-538.
31. Asch HL, Winston JS, Edge SB, Stomper PC, Asch BB. Downregulation of gelsolin expression in human breast ductal carcinoma in situ with and without invasion. Breast Cancer Res Treat 1999 May; 55(2):179-188.
32. Gay F, Estornes Y, Saurin JC, Joly-Pharaboz MO, Friederich E, Scoazec JY, Abello J. In colon carcinogenesis, the cytoskeletal protein gelsolin is down- regulated during the transition from adenoma to carcinoma .Hum Pathol 2008 Oct; 39 (10):1420-1430.
33. Lee HK, Driscoll D, Asch H, Asch B, Zhang PJ. Downregulated gelsolin expres- sion in hyperplastic and neoplastic lesions of the prostate. Prostate 1999 Jun; 40 (1):14-19.
34. Shieh DB, Chen IW, Wei TY, Shao CY, Chang HJ, Chung CH, Wong TY, Jin YT. Tissue expression of gelsolin in oral carcinogenesis progression and its clinic- pathological implications. Oral Oncology 2006 Jul; 42 (6):599-606.
35. Shieh DB, Godleski J, Herndon JE 2nd, Azuma T, Mercer H, Sugarbaker DJ, Kw-iatkowski DJ.Cell motility as a prognostic factor in stageⅠnonsmall cell lung carcinoma: the role of gelsolin expression . Cancer 1999 Jan; 85(1):47-57.
36. Liu S, Sun MZ, Tang JW, Wang Z, Sun C, Greenaway FT. High -performance liquid chromatography/nanoelectrospray ionization tandem mass spectrometry, two-dimensional difference in-gel electrophoresis and gene microarray identify- cation of lymphatic metastasis-associated biomarkers. R C M, 2008 Oct; 22 (20): 3172-3178.
37.孙成荣,唐建武,孙明忠,刘淑清,张宏颖,王波,宋波,张亚楠,张竹清,赵志英.采用定量蛋白质组学技术筛选小鼠肝癌淋巴道转移相关蛋白.生物化学与生物物理进展. 2007 Mar; 4 (8): 856-864.
38. Song B, Tang JW, Wang B, et al. Screening for lymphatic metastasis-associated genes in mouse hepatocarcinoma cell lines Hca-F and Hca-P using gene chip .癌症2005 Jul; 24(7):774-780.
39. Walsh N, Dowling P, O'Donovan N, Henry M, Meleady P, Clynes M.Aldehyde dehydrogenase 1A1 and gelsolin identified as novel invasion-modulating factors in conditioned medium of pancreatic cancer cells. Proteomics 2008 Dec; 71 (5):561-571.
40. Koya RC, Fujita H, Shimizu S, Ohtsu M, Takimoto M, Tsujimoto Y, Kuzumaki N. Gelsolin inhibits apoptosis by blocking mitochondrial membrane potential loss and cytochromec release.Biol Chem 2000 Aug; 275(20):15343-15349.
41. Ohtsu M, Sakai N, Fujita H, Kashiwagi M, Gasa S, Shimizu S, Eguchi Y, Tsujim- oto Y, Sakiyama Y, Kobayashi K, Kuzumaki N.Inhibition of apoptosis by the actin-regulatory protein gelsolin. EMBO 1997 Aug; 16(15):4650-4656.
42. Klampfer L, Huang J, Sasazuki T,Shirasawa S, Augenlicht L. Oncogenic Ras promotes butyrate-induced apoptosis through Inhibition of gelsolin expression . J Biol Chem 2004 Aug; 279(35):36680-36688.
43. Garcia CD, Knock E, Jabado N, Rozen R. Intestinal neoplasia induced by low dietary folate is associated with altered tumor expression profiles and decreased apoptosis in mouse normal intestine. J Nutr 2009 Mar; 139(3):488-494.
44. Endres M, Fink K, Zhu J, Stagliano NE, Bondada V, Geddes JW, Azuma T, Mattson MP, Kwiatkowski DJ, Moskowitz MA.Neuroprotective effects of gelsolin during murine stroke.JClinInvest 1999 Feb;103(3):3472-354
1. Nabeshima K, Inoue T, Shimao Y, Kataoka H, Koono M.Cohort migration of carcinoma cells: differentiated colorectal carcinoma cells move as coherent cell clusters or sheets. Histol Histopathol 1999 Oct; 14(4):1183-1197.
2. Song B, Tang JW, Wang B, Cui XN, Hou L, Sun L, Mao LM, Zhou CH, Du Y, Wang LH, Wang HX, Zheng RS, Sun L. Identify lymphatic metastasis2associated genes in mouse hepatocarcinoma cell lines using gene chip. World J Gast- roenterol 2005 Mar; 11(10):1463-1472.
3.孙成荣,唐建武,孙明忠,刘淑清,张宏颖,王波,宋波,张亚楠,张竹清,赵志英.采用定量蛋白质组学技术筛选小鼠肝癌淋巴道转移相关蛋白.生物化学与生物物理进展2007, 34 (8): 856-864.
4. Liu SQ, Sun MZ, Tang JW, Wang Z, Sun CR, Greenaway FT. High-performance liquid chromatography/nanoelectrospray ionization tandem mass spectrometry, two-dimensional difference in-gel electrophoresis and gene microarray iden- tification of lymphatic metastasis-associated biomarkers. RCM 2008, 22 (8): 3172-3178.
5.凌茂英,王明辉,郭伶伶,王波. Hca/ 16A32F及Hca/ A22P两株小鼠淋巴道转移肝癌细胞系的特性研究.中华医学杂志.1995 Mar ;75 (3):170-171.
6. Yamaguchi H., Condeelis J. Regμlation of the actin cytoskeleton in cancer cell migration and invasion. Biochim Biophys Acta 2007 May; 1117 (5): 642-652.
7. Tanaka M, Müllauer L, Ogiso Y, Fujita H, Moriya S, Furuuchi K, Harabayashi T, Shinohara N, Koyanagi T, Kuzumaki N. Gelsolin: A Candidate for Suppressor of Human Bladder Cancer .Cancerresearch 1995 Aug; 55 (8 ): 3228-3232.
8. Rao J,Seligson D,Visapaa H,Horvath S, Eeva M, Michel K, Pantuck A, Belldegrun A, Palotie A. Tissue microarray analysis of cytoskeletal actin- associated biomarkers gelsolin and E-cadherin in urothelial carcinoma. Cancer 2002 Sep; 95 (4): 1247-1257.
9. Thor AD, Edgerton SM, Liu S, Moore DH 2nd, Kwiatkowski DJ. Gelsolin as a negative prognostic factor and effector of motility in erbB-positive epidermal growth factor receptor-positive breast cancers .Clin Cancer Res .2001 Aug; 7 (8): 2415-2424.
10. Yang J, Ramnath N, Moysich KB, Asch HL, Swede H, Alrawi SJ, Huberman J, Geradts J, Brooks JS, Tan D. Prognostic significance of MCM2, Ki-67 andgelsolin in non-small cell lung cancer.BMC Cancer 2006 Aug; 203(6): 1-10.
11. Hou L, Li Y, Jia YH, Wang B, Xin Y, Ling MY, LüS. Molecμlar mechanism about lympho genous metastasis of hepatocarcinoma cells in mice. World J Gastr- oenterol 2001 Aug;7(4):532-536.
12. Van dA A, De CV, Van IK, Bruyneel E, Boucherie C, Bracke M, Vandekerckhove J, Gettemans J .Downregulation of Gelsolin family proteins counteracts cancer cell invasion in vitro .Cancer Letters 2007 Sep; 255(1):57-70.
13.史伟峰,陈同钰,鲁常青,谈敏,谈炎,张学光.Gelsolin分子在乳腺癌中的表达.肿瘤2002 Jul;3(4):289-293.
14. Shieh DB, Godleski J, Herndon JE 2nd, Azuma T, Mercer H, Sugarbaker DJ, Kwiatkowski DJ. Cell motility as a prognostic factor in stageⅠnonsmall cell lung carcinoma: the role of gelsolin expression. Cancer 1999 Jan; 85(1):47-57.
1.凌茂英,王明辉,郭伶伶,王波. Hca/ 16A32F及Hca/ A22P两株小鼠淋巴道转移肝癌细胞系的特性研究.中华医学杂志1995 Mar;75 (3):170-171.
2. Song B, Tang JW, Wang B, Cui XN, Hou L, Sun L, Mao LM, Zhou CH, Du Y, Wang LH, Wang HX, Zheng RS, Sun L. Identify lymphatic metastasis2associated genes in mouse hepatocarcinoma cell lines using gene chip. World J Gastroenterol 2005 Mar; 11(10):1463-1472.
3.孙成荣,唐建武,孙明忠,刘淑清,张宏颖,王波,宋波,张亚楠,张竹清,赵志英.采用定量蛋白质组学技术筛选小鼠肝癌淋巴道转移相关蛋白.生物化学与生物物理进展2007 Mar;4 (8): 856-864.
4. Liu SQ, Sun MZ, Tang JW, Wang Z, Sun CR, Greenaway FT. High-performance liquid chromatography/nanoelectrospray ionization tandem mass spectrometry, two-dimensional difference in-gel electrophoresis and gene microarray identi- fication of lymphatic metastasis-associated biomarkers. RCM 2008 Oct; 22(20): 3172-3178.
5. H Yamaguchi, J Condeelis. Regulation of the actin cytoskeleton in cancer cell migration and invasion.Biochim Biophys Acta. 2007 May; 1773 (5): 642 - 652.
6. McGough AM, Staiger CJ, Min JK, Simonetti KD. The gelsolin family actin regulatory proteins: modular structures, versatile functions. FEBS Letters 2003 Sep 25; 552(2-3):75-81.
7. Dirk G, Mark A K. Therapeutic application of RNAi: is mRNA targeting finally ready for prime time? J Clin Invest 2007 Dec; 117(12):3633-3641.
8. Nathanson S D. Insights into the mechanisms of lymph node metastasis. Cancer 2003 Jul 15; 98(2):413-423.
9. Van AA, De CV, Van IK, Bruyneel E, Boucherie C, Bracke M, Vandekerckhove J, Gettemans J .Downregulation of gelsolin family proteins counteracts cancer cell invasion in vitro .Cancer Letters 2007 Sep;25 (1):57-70.
10. Shieh DB, Godleski J, Herndon JE 2nd, Azuma T, Mercer H, Sugarbaker DJ, Kwiatkowski DJ. Cell motility as a prognostic factor in stageⅠnonsmall cell lung carcinoma: the role of gelsolin expression. Cancer 1999 Jan; 85 (1):47-57.
11. Lee NS, Dohjima T, Bauer G, Li H, Li MJ, Ehsani A, Salvaterra P, Rossi J. Ex- pression of small interfering RNAs targeted against HIV- 1 rev transcripts in human cells. Nat Biotechnol 2002 May; 20(5):500-505.
12. Angell SM, Banlcombe DC. Angell SM, Baμlcombe DC. Consistent gene silencing in transgenic plants expressing a replicating potato virus X RNA. EMBO J 1997 Jun; 16(12):3675-3684.
1.凌茂英,王明辉,郭伶伶,王波. Hca/ 16A32F及Hca/ A22P两株小鼠淋巴道转移肝癌细胞系的特性研究.中华医学杂志, 1995 Mar;75 (3): 170 - 171.
2. Cui XN, Tang JW, Hou L, Song B, Ban LY. Identification of differentially expressed genes in mouse hepatocarcinoma ascites cell line with low potential of lymphogenous metastasis. World J Gastroenterol. 2006 Nov;12(42):6893-6897.
3. Song B, Tang JW, Wang B, Cui XN, Hou L, Sun L, Mao LM, Zhou CH, Du Y, Wang LH, Wang HX, Zheng RS, Sun L. Identify lymphatic metastasis2associated genes in mouse hepatocarcinoma cell lines using gene chip. World J Gast roenterol 2005 Mar; 11(10):1463-1472.
4. Liu SQ, Sun MZ, Tang JW, Wang Z, Sun CR, Greenaway FT. High-performance liquid chromatography/nanoelectrospray ionization tandem mass spectrometry, two-dimensional difference in-gel electrophoresis and gene microarray identify- cation of lymphatic metastasis-associated biomarkers. RCM 2008 Oct; 22(20): 3172-3178.
5. McGough AM, Staiger CJ, Min JK, Simonetti KD. The gelsolin family actin regulatory proteins: modular structures, versatile functions. FEBS Letters 2003 Sep 25; 552(2-3):75-81.
6. Rao J, Seligson D, Visapaa H, Horvath S, Eeva M, Michel K, Pantuck A, Belldegrun A, Palotie A. Tissue microarray analysis of cytoskeletal actin- associated biomarkers gelsolin and E-cadherin in urothelial carcinoma . Cancer 2002 Sep; 95(6):1247-1257.
7. Shieh DB, Godleski J, Herndon JE 2nd, Azuma T, Mercer H, Sugarbaker DJ, Kwiatkowski DJ. Cell motility as a prognostic factor in stageⅠnonsmall cell lung carcinoma: the role of gelsolin expression . Cancer 1999 Jan; 85(1):47-57.
8. Hou G, Xue L, Lu Z, Fan T, Tian F, Xue Y. An activated Mtor/p70S6K singaling pathway in esophageal squamous cell carcinoma cell lines and inhibitioan of the pathway by rapamycin and siRNAs gainst mTOR. Cancer Lett 2007 Aug; 253(2): 236-248.
9.高进,章静波.癌的侵袭与转移基础与临床.1996 Mar.
10. Kim CS, Furuya F, Ying H, Kato Y, Hanover JA, Cheng SY. Gelsolin: a novel thyroid hormone receptor-beta interacting protein that modulates tumor progr- ession in a mouse model of follicular thyroid cancer. Endocrinology 2007 Mar;148(3):1306-1312.
11.史伟峰,陈同钰,鲁常青,谈敏,谈炎,张学光.Gelsolin分子在乳腺癌组织中的表达研究.肿瘤2002 Jul;22(4):289-293.
12. Thompson CC, Ashcroft FJ, Patel S, Saraga G, Vimalachandran D, Prime W, Campbell F, Dodson A, Jenkins RE, Lemoine NR, Crnogorac-Jurcevic T, Yin HL, Costello E. Pancreatic cancer cells overexpress gelsolin familycapping proteins which contribute to their cell motility .Gut 2007 Jan;56(1):95-106.
13. Gay F, Estornes Y, Saurin JC, Joly-Pharaboz MO, Friederich E, Scoazec JY, Abello J.In colon carcinogenesis, the cytoskeletal protein gelsolin is down- regμlated during the transition from adenoma to carcinoma .Hum Pathol 2008 Oct;39(10):1420-1430.
14. B Shieh, IW Chen, TY Wei, et al .Tissue expression of gelsolin in oral carcinogenesis progressionand its clinicopathological implications. Oral Oncol 2006 Jul; 42(6):599-606.
15. Sj?blom T, Jones S, Wood LD, Parsons DW, Lin J, Barber TD, Mandelker D, Leary RJ, Ptak J, Silliman N, Szabo S, Buckhaults P, Farrell C, Meeh P, Markowitz SD, Willis J, Dawson D, Willson JK, Gazdar AF, Hartigan J, Wu L, Liu C, Parmigiani G, Park BH, Bachman KE, Papadopoulos N, Vogelstein B, Kinzler KW, Velculescu VE.The consensus coding sequences of human breast and colorectal cancers. Science 2006 Oct; 314(5797):268-274.
16. Azuma T, Witke W, Stossel TP, Hartwig JH, Kwiatkowski DJ. Gelsolin is a downstream effector of Rac for fibroblast motility.EMBO J 1998 Mar; 17 (5): 1362-1370.
17. Laine RO, Phaneuf KL, Cunningham CC, Kwiatkowski D, Azuma T, Southwick FS.Gelsolin, a protein that caps the barbed ends and severs actin filaments, enhances the actin-based motility of Listeria monocytogenes in host cells.Infect Immun 1998 Aug;66(8):3775-3782.
18. Chen P, Murphy-Ullrich JE, Wells A.A role for gelsolin in actuating epidermal growth factor receptor-mediated cell motility.Cell Biol 1996 Aug;134(3): 689- 698.
19. Lader AS, Lee JJ, Cicchetti G, Kwiatkowski DJ. Mechanisms of gelsolin- dependent and -independent EGF-stimulated cell motility in a human lung epithelial cell line. Exp Cell Res 2005 Jul; 307(1):153-163.
20. Chellaiah M, Kizer N, Silva M, Alvarez U, Kwiatkowski D, Hruska KA .Gelsolindeficiency blocks podosome assembly and produces increased bone mass and strength. J Cell Biol 2000 Feb; 148(4):665-678.
21. Van den Abbeele A, De Corte V, Van Impe K, Bruyneel E, Boucherie C, Bracke M, Vandekerckhove J, Gettemans J .Downregμlation of gelsolin family proteins counteractscancer cell invasion in vitro .Cancer Letters 2007 Sep;255(1):57-70.
22. Koya RC, Fujita H, Shimizu S, Ohtsu M, Takimoto M, Tsujimoto Y, Kuzumaki N. Gelsolin inhibits apoptosis by blocking mitochondrial membrane potential loss and cytochromec release.Biol Chem 2000 May;275(20):15343-15349.
23. Ohtsu M, Sakai N, Fujita H, Kashiwagi M, Gasa S, Shimizu S, Eguchi Y, Tsujimoto Y, Sakiyama Y, Kobayashi K, Kuzumaki N.Inhibition of apoptosis by the actin - regulatory protein gelsolin. EMBO 1997 Aug; 16(15):4650-4656.
24. Garcia CD, Knock E, Jabado N, Rozen R. Intestinal neoplasia induced by low dietary folate is associated with altered tumor expression profiles and decreased apoptosis in mouse normal intestine. Nutr 2009 Mar; 139(3):488-494.